Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE

VTEval Project - Three Observational, Prospective Cohort Studies Including Biobanking to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in Venous Thromboembolism

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Venous thromboembolism (VTE) with its two clinical manifestations deep vein thrombosis (DVT) and pulmonary embolism (PE) is a life-threatening disease that is associated with considerable morbidity and mortality. The incidence of VTE increases with age and it - as the third most common cardiovascular disease after ischemic heart disease and stroke - represents an important public health problem in industrialized countries with several aspects in need to be addressed. VTEval Project includes three long-term prospective observational studies to evaluate and improve VTE diagnostics and management, treatment and outcome. The aims of the project include a systematic assessment of VTE, i.e. disease status (symptoms, clinical and subclinical aspects) and risk profiles (classic, psychosocial and environmental factors), using a system-oriented approach. VTEval collects three large prospective cohorts of patients with suspected and incident VTE consisting of individuals with a clinical suspicion of acute PE, individuals with a clinical suspicion of acute DVT, and individuals with incidental diagnosis of VTE). The standardized and harmonized data acquisition of the study establishes a sustainable resource for comprehensive research on VTE, thus providing the basis for both short- and long-term analysis.

Who May Be Eligible (Plain English)

Who May Qualify: - Age ≥18 years and Informed written consent - Clinical condition: - Cohort 1: Clinical suspicion of acute PE (with or without DVT) - Cohort 2: Clinical suspicion of acute DVT (without symptomatic PE) - Cohort 3: Incidentally diagnosed VTE Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age ≥18 years and Informed written consent * Clinical condition: * Cohort 1: Clinical suspicion of acute PE (with or without DVT) * Cohort 2: Clinical suspicion of acute DVT (without symptomatic PE) * Cohort 3: Incidentally diagnosed VTE

Locations (1)

University Medical Center of the Johannes Gutenberg University Mainz
Mainz, Rhineland-Palatinate, Germany